Extraintestinal manifestations in inflammatory bowel disease. (Q34488386)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437620%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

review article

1 reference

title

Extraintestinal manifestations in inflammatory bowel disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437620%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

16 January 2020

main subject

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437620%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

7

Giovanni Gasbarrini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437620%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1

Silvio Danese

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437620%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

8

Antonio Gasbarrini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437620%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Stefano Semeraro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437620%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Italia Roberto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437620%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Franco Scaldaferri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437620%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Giuseppe Fedeli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437620%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

English

0 references

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437620%20AND%20SRC:MED&resulttype=core&format=json

World Journal of Gastroenterology

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437620%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437620%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437620%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

7227-7236

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437620%20AND%20SRC:MED&resulttype=core&format=json

A review of the use of infliximab to manage cutaneous dermatoses

16 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Liver abscess in inflammatory bowel disease: report of two cases and review of the literature

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Review article: skin complications associated with inflammatory bowel disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Review article: bone disease in inflammatory bowel disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Review article: joint involvement in inflammatory bowel disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Iron, anaemia, and inflammatory bowel diseases.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Rare extraintestinal manifestations of inflammatory bowel disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Ocular manifestations of inflammatory bowel disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

The osteoporosis care gap in Canada

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Infliximab maintenance therapy for fistulizing Crohn's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Review article: inherited thrombophilia in inflammatory bowel disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

IgA antiglomerular basement membrane nephritis associated with Crohn's disease: a case report and review of glomerulonephritis in inflammatory bowel disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Infliximab in the treatment of Crohn's disease: a user's guide for clinicians

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

6 July 2018

Anemia and lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Fistulas to the urinary system in Crohn's disease: clinical features and outcomes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Iron and inflammatory bowel disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Metastatic Crohn's disease: case report of an unusual variant and review of the literature

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Progression of primary biliary cirrhosis after proctocolectomy for ulcerative colitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Comparative tolerability of treatments for inflammatory bowel disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Complications of inflammatory bowel disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Fracture risk is increased in Crohn's disease, but not in ulcerative colitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Genetic markers may predict disease behavior in patients with ulcerative colitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Adhesion molecules in primary biliary cirrhosis and primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Clinical patterns of familial inflammatory bowel disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Association of primary sclerosing cholangitis with HLA-B8.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Vascular complications of inflammatory bowel disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Immunochemical studies on sialic acid-containing lipopolysaccharides from enterobacterial species.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Effect of inflammatory cytokines on hypoxia-induced erythropoietin production

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Ankylosing spondylitis and inflammatory bowel disease. II. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Clinical investigation of methotrexate in the treatment of ankylosing spondylitis

6 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

Risk of colorectal neoplasia in patients with primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

Long-Term Effect of Corticosteroid Treatment in Primary Sclerosing Cholangitis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

Evidence-based treatment algorithm for mild to moderate Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

Inflammatory bowel disease and the risk of fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

The association between corticosteroid use and development of fractures among IBD patients in a population-based database

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34).

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

Venous thromboembolism in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Etanercept treatment in resistant spondyloarthropathy: imaging, duration of effect and efficacy on reintroduction.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Is 99mTc human immunoglobulin G scintigraphy (HIG-scan) useful for the detection of spinal inflammation in ankylosing spondylitis?

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications?

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725142

Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease

27 October 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

Musculoskeletal manifestations in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I46.7227

Inflammatory bowel disease promotes venous thrombosis earlier in life

21 January 2018

1 reference

12 December 2020

Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development

1 reference

12 December 2020

Pleuropericarditis and disseminated intravascular coagulation in ulcerative colitis

1 reference

12 December 2020

1 reference

12 December 2020

Lymphocytic encephalomyeloneuritis as a neurologic complication of ulcerative colitis

1 reference

12 December 2020

Treatment of acute uveitis associated with Crohn's disease and sacroileitis with infliximab

1 reference

12 December 2020

The effect of infliximab on extraintestinal manifestations of Crohn's disease

1 reference

12 December 2020

Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: study of 511 subjects at a single center

1 reference

12 December 2020

Treatment of pyoderma gangrenosum with etanercept

1 reference

12 December 2020

Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study

1 reference

12 December 2020

Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease

1 reference

12 December 2020

Renal stone formation in patients with inflammatory bowel disease

1 reference

12 December 2020

Effects of low copper intake on dimethylhydrazine-induced colon cancer in rats

1 reference

12 December 2020

Genetic factors determine extent of bone loss in inflammatory bowel disease

1 reference

12 December 2020

Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms

1 reference

12 December 2020

Characteristics and evolution of extraintestinal manifestations associated with ulcerative colitis after proctocolectomy

1 reference

12 December 2020

Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study

1 reference

12 December 2020

Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's disease

1 reference

12 December 2020

The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota

1 reference

12 December 2020

Methotrexate in Crohn's disease: long-term efficacy and toxicity

1 reference

12 December 2020

Quantitative sacroiliac scintigraphy in patients with crohn' disease

1 reference

12 December 2020

The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study

1 reference

12 December 2020

Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia

1 reference

12 December 2020

[Myositis--a rare complication of Crohn disease]

1 reference

12 December 2020

Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids

1 reference

12 December 2020

Primary sclerosing cholangitis

1 reference

12 December 2020

1 reference

12 December 2020

Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?

1 reference

12 December 2020

Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease

1 reference

12 December 2020

Thrombotic complications in inflammatory bowel disease: a multifactorial etiology

1 reference

12 December 2020

Renal lesions associated with chronic ulcerative colitis

1 reference

12 December 2020

Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis

1 reference

12 December 2020

[Renal amyloidosis as initial clinical manifestation of Crohn's disease]

1 reference

12 December 2020

Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease

1 reference

12 December 2020

Dermatologic manifestations of Crohn disease in children: response to infliximab

1 reference

12 December 2020

Bone density improves with disease remission in patients with inflammatory bowel disease

1 reference

12 December 2020

[Treatment of refractory anterior diffuse scleritis with infliximab]

1 reference

12 December 2020

[Involvement of the peripheral nervous system in Crohn disease]

1 reference

12 December 2020

Immune cell trafficking in uterus and early life is dominated by the mucosal addressin MAdCAM-1 in humans

1 reference

12 December 2020

Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease

1 reference

12 December 2020

Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group

1 reference

12 December 2020

Response of cutaneous Crohn's disease to infliximab and methotrexate

1 reference

12 December 2020

Giant cell myocarditis, in a patient with Crohn's disease, treated with etanercept--a tumour necrosis factor-alpha antagonist

1 reference

12 December 2020

American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V11.I46.7227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437620%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437620%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PubMed publication ID

16437620

1 reference